Top upgrades and downgrades on 9/22
Top upgrades and downgrades on 9/22
Upgrades
升級
Argus Research upgraded the previous rating for $Simon Property(SPG.US)$ from Hold to Buy. In the second quarter, Simon Property Group showed an EPS of $3.24, compared to $2.12 from the year-ago quarter. The stock has a 52-week-high of $137.38 and a 52-week-low of $59.35. At the end of the last trading period, Simon Property Group closed at $130.38.
According to BMO Capital, the prior rating for $Teck Resources Ltd(TECK.US)$ was changed from Market Perform to Outperform. Teck Resources earned $0.51 in the second quarter, compared to $0.12 in the year-ago quarter. At the moment, the stock has a 52-week-high of $27.08 and a 52-week-low of $11.91. Teck Resources closed at $23.19 at the end of the last trading period.
According to $Ambarella Inc(AMBA.US)$ ording to WBB Securities, the prior rating for $Cidara Therapeutics Inc(CDTX.US)$ was changed from Buy to Strong Buy. In the second quarter, Cidara Therapeutics showed an EPS of $0.18, compared to $0.45 from the year-ago quarter. The stock has a 52-week-high of $3.28 and a 52-week-low of $1.46. At the end of the last trading period, Cidara Therapeutics closed at $2.14.
For $Xponential Fitness, Inc.(XPOF.US)$, Raymond James upgraded the previous rating of Market Perform to Strong Buy. Xponential Fitness earned $0.50 in the second quarter. Xponential Fitness closed at $10.34 at the end of the last trading period.
For, Keybanc upgraded the previous rating of Sector Weight to Overweight. In the second quarter, Ambarella showed an EPS of $0.35, compared to $0.06 from the year-ago quarter. At the moment, the stock has a 52-week-high of $153.18 and a 52-week-low of $48.35. Ambarella closed at $148.92 at the end of the last trading period.
Argus Research上調了之前的評級，$Simon Property(SPG.US)$從持有到買入。西蒙地產集團(Simon Property Group)第二季度每股收益為3.24美元，而去年同期為2.12美元。該股目前的52周高點為137.38美元，52周低點為59.35美元。上一交易期尾盤，西蒙地產集團收報130.38美元。
根據蒙特利爾銀行資本公司(BMO Capital)的數據，之前的評級為$Teck Resources Ltd(TECK.US)$從市場表現改為跑贏大盤。Teck Resources第二季度盈利0.51美元，而去年同期為0.12美元。目前，該股的52周高點為27.08美元，52周低點為11.91美元。泰克資源上交易期尾盤報23.19美元。
根據$Ambarella Inc(AMBA.US)$根據WBB證券的訂單，優先評級為$Cidara治療公司(CDTX.US)$從買入改為強力買入。在第二季度，Cidara治療公司顯示每股收益為0.18美元，而去年同期為0.45美元。該股目前的52周高點為3.28美元，52周低點為1.46美元。上一交易期尾盤，Cidara Treeutics收報2.14美元。
為$Xponential Fitness，Inc.(XPOF.US)$此前，Raymond James將市場表現評級上調至強力買入。Xponential Fitness第二季度盈利0.50美元。Xponential Fitness上交易日尾盤報10.34美元。
例如，Keybanc將之前對行業權重的評級上調至加碼。第二季度，Ambarella的每股收益為0.35美元，而去年同期為0.06美元。目前，該股的52周高點為153.18美元，52周低點為48.35美元。安巴雷拉上交易期尾盤報148.92美元。
Downgrades
降級
William Blair downgraded the previous rating for $InnovAge Holding Corp.(INNV.US)$ from Outperform to Market Perform. InnovAge Holding earned $0.05 in the fourth quarter, compared to $0.09 in the year-ago quarter. At the moment, the stock has a 52-week-high of $27.18 and a 52-week-low of $11.45. InnovAge Holding closed at $11.65 at the end of the last trading period.
According to Morgan Stanley, the prior rating for $RE/MAX Holdings Inc(RMAX.US)$ was changed from Overweight to Equal-Weight. RE/MAX Hldgs earned $0.63 in the second quarter, compared to $0.38 in the year-ago quarter. The current stock performance of RE/MAX Hldgs shows a 52-week-high of $43.85 and a 52-week-low of $29.40. Moreover, at the end of the last trading period, the closing price was at $31.50.
For $FedEx(FDX.US)$, Raymond James downgraded the previous rating of Outperform to Market Perform. In the first quarter, FedEx showed an EPS of $4.37, compared to $4.87 from the year-ago quarter. The current stock performance of FedEx shows a 52-week-high of $319.90 and a 52-week-low of $230.27. Moreover, at the end of the last trading period, the closing price was at $252.07.
For $Axcella Health Inc(AXLA.US)$, Goldman Sachs downgraded the previous rating of Buy to Neutral. In the second quarter, Axcella Health showed an EPS of $0.42, compared to $0.48 from the year-ago quarter. At the moment, the stock has a 52-week-high of $6.84 and a 52-week-low of $2.98. Axcella Health closed at $3.15 at the end of the last trading period.
For $Frequency Therapeutics Inc(FREQ.US)$, Goldman Sachs downgraded the previous rating of Buy to Neutral. For the second quarter, Frequency Therapeutics had an EPS of $0.52, compared to year-ago quarter EPS of $0.19. The stock has a 52-week-high of $58.37 and a 52-week-low of $6.75. At the end of the last trading period, Frequency Therapeutics closed at $7.30.
According to Goldman Sachs, the prior rating for $Vir Biotechnology(VIR.US)$ was changed from Buy to Neutral. Vir Biotechnology earned $0.46 in the second quarter, compared to $0.27 in the year-ago quarter. The stock has a 52-week-high of $141.01 and a 52-week-low of $25.31. At the end of the last trading period, Vir Biotechnology closed at $51.02.
According to Goldman Sachs, the prior rating for $FibroGen Inc(FGEN.US)$ was changed from Neutral to Sell. In the second quarter, FibroGen showed an EPS of $1.45, compared to $0.95 from the year-ago quarter. The current stock performance of FibroGen shows a 52-week-high of $57.21 and a 52-week-low of $11.08. Moreover, at the end of the last trading period, the closing price was at $11.24.
According to Raymond James, the prior rating for $OraSure Technologies Inc(OSUR.US)$ was changed from Outperform to Market Perform. In the second quarter, OraSure Technologies showed an EPS of $0.02, compared to $0.16 from the year-ago quarter. The current stock performance of OraSure Technologies shows a 52-week-high of $17.79 and a 52-week-low of $8.58. Moreover, at the end of the last trading period, the closing price was at $13.34.
B of A Securities downgraded the previous rating for $Vale SA(VALE.US)$ from Buy to Neutral. Vale earned $1.49 in the second quarter, compared to $0.19 in the year-ago quarter. The current stock performance of Vale shows a 52-week-high of $23.18 and a 52-week-low of $10.29. Moreover, at the end of the last trading period, the closing price was at $15.88.
Susquehanna downgraded the previous rating for $Coherent Inc(COHR.US)$ from Positive to Neutral. Coherent earned $1.81 in the third quarter, compared to $0.52 in the year-ago quarter. The current stock performance of Coherent shows a 52-week-high of $270.99 and a 52-week-low of $103.00. Moreover, at the end of the last trading period, the closing price was at $252.38.
威廉·布萊爾下調了之前的評級，$Innovage Holding Corp.(INNV.US)$從跑贏大盤到大盤表現。Innovage Holding第四季度盈利0.05美元，而去年同期為0.09美元。目前，該股的52周高點為27.18美元，52周低點為11.45美元。Innovage Holding上一交易期尾盤報11.65美元。
據摩根士丹利介紹，該公司此前的評級為$RE/MAX控股公司(RMAX.US)$從超重變為等重。Re/Max Hldgs第二季度的利潤為0.63美元，而去年同期為0.38美元。RE/Max Hldgs目前的股票表現顯示，52周高點為43.85美元，52周低點為29.40美元。而且，在上個交易期結束時，收盤價為31.50美元。
為$聯邦快遞(FDX.US)$根據雷蒙德·詹姆斯(Raymond James)的評級，雷蒙德將之前的評級下調至表現優於市場表現。聯邦快遞第一季度每股收益為4.37美元，而去年同期為4.87美元。聯邦快遞目前的股票表現顯示，52周高點為319.90美元，52周低點為230.27美元。而且，在上個交易期結束時，收盤價為252.07美元。
為$Axcella Health Inc.(AXLA.US)$(投行觀點)，高盛將之前的買入評級下調至中性第二季度，Axcella Health顯示每股收益為0.42美元，而去年同期為0.48美元。目前，該股的52周高點為6.84美元，52周低點為2.98美元。Axcella Health上一交易期尾盤報3.15美元。
為$Frequency Treateutics Inc.(FREQ.US)$(投行觀點)，高盛將之前的買入評級下調至中性第二季度，頻率治療公司的每股收益為0.52美元，而去年同期為0.19美元。該股目前的52周高點為58.37美元，52周低點為6.75美元。上一交易期尾盤，Frequency Treeutics收報7.30美元。
根據高盛(Goldman Sachs)的説法，之前的評級為$Vir Biotechnology(VIR.US)$從買入改為中性。VIR生物技術公司第二季度的利潤為0.46美元，而去年同期為0.27美元。該股目前的52周高點為141.01美元，52周低點為25.31美元。上交易期尾盤，Vir Biotech收報51.02美元。
根據高盛(Goldman Sachs)的説法，之前的評級為$FibroGen Inc.(FGEN.US)$從中性改為賣出。第二季度，FibroGen顯示每股收益為1.45美元，而去年同期為0.95美元。FibroGen目前的股票表現顯示，52周高點為57.21美元，52周低點為11.08美元。而且，在上個交易期結束時，收盤價為11.24美元。
根據雷蒙德·詹姆斯(Raymond James)的説法，之前的評級為$OraSure Technologies Inc.(OSUR.US)$從跑贏大盤變為大盤表現。第二季度，OraSure Technologies的每股收益為0.02美元，而去年同期為0.16美元。目前OraSure Technologies的股票表現顯示，52周高點為17.79美元，52周低點為8.58美元。而且，在上個交易期結束時，收盤價為13.34美元。
B of A Securities下調之前的評級為$淡水河谷(VALE.US)$從買入到中性。淡水河谷第二季度盈利1.49美元，而去年同期為0.19美元。淡水河谷目前的股票表現顯示，52周高點為23.18美元，52周低點為10.29美元。而且，在上個交易期結束時，收盤價為15.88美元。
Susquehanna下調了之前的評級，$Coherent Inc.(COHR.US)$從正值到中性。Coherent第三季度盈利1.81美元，而去年同期為0.52美元。Coherent目前的股票表現顯示，52周高點為270.99美元，52周低點為103.00美元。而且，在上個交易期結束時，收盤價為252.38美元。
Initiations
啟蒙行動
With a Buy rating, Alliance Global Partners initiated coverage on $ICECURE MEDICAL LTD(ICCM.US)$. The price target seems to have been set at $14.50 for Icecure Medical. Icecure Medical closed at $9.00 at the end of the last trading period.
JP Morgan initiated coverage on $ZIM Integrated Shipping(ZIM.US)$ with an Underweight rating. The price target for ZIM Integrated Shipping is set to $46.02. In the second quarter, ZIM Integrated Shipping earned $7.38. The stock has a 52-week-high of $62.20 and a 52-week-low of $11.34. At the end of the last trading period, ZIM Integrated Shipping closed at $55.89.
Evercore ISI Group initiated coverage on $SunPower(SPWR.US)$ with an Outperform rating. The price target for SunPower is set to $27.00. In the second quarter, SunPower showed an EPS of $0.06, compared to $0.22 from the year-ago quarter. The current stock performance of SunPower shows a 52-week-high of $57.52 and a 52-week-low of $9.54. Moreover, at the end of the last trading period, the closing price was at $21.09.
With a Buy rating, UBS initiated coverage on $LI-CYCLE HOLDINGS CORP(LICY.US)$. The price target seems to have been set at $15.00 for Li-Cycle Holdings. For the third quarter, Li-Cycle Holdings had an EPS of $2.88, compared to year-ago quarter EPS of $0.86. Li-Cycle Holdings closed at $9.85 at the end of the last trading period.
BTIG initiated coverage on $HUMACYTE INC(HUMA.US)$ with a Buy rating. The price target for Humacyte is set to $19.00. At the end of the last trading period, Humacyte closed at $13.85.
With an Overweight rating, Wells Fargo initiated coverage on $Vimeo Inc(VMEO.US)$. The price target seems to have been set at $47.00 for Vimeo. Vimeo earned $0.02 in the second quarter, compared to $0.05 in the year-ago quarter. At the moment, the stock has a 52-week-high of $52.06 and a 52-week-low of $29.17. Vimeo closed at $32.39 at the end of the last trading period.
For $Poshmark, Inc.(POSH.US)$, Needham initiated coverage, by setting the current rating at Hold. Interestingly, in the second quarter, Poshmark's EPS was $0.04. The current stock performance of Poshmark shows a 52-week-high of $104.98 and a 52-week-low of $23.58. Moreover, at the end of the last trading period, the closing price was at $23.59.
DZ Bank initiated coverage on $ServiceNow Inc(NOW.US)$ with a Buy rating. The price target for ServiceNow is set to $725.00. ServiceNow earned $1.42 in the second quarter, compared to $1.23 in the year-ago quarter. The current stock performance of ServiceNow shows a 52-week-high of $681.10 and a 52-week-low of $446.20. Moreover, at the end of the last trading period, the closing price was at $654.20.
With an Overweight rating, Morgan Stanley initiated coverage on $Jackson Financial(JXN.US)$. The price target seems to have been set at $37.00 for Jackson Financial. Jackson Financial earned $6.74 in the second quarter. Moreover, at the end of the last trading period, the closing price was at $26.53.
Cantor Fitzgerald initiated coverage on $IMV Inc(IMV.US)$ with an Overweight rating. The price target for IMV is set to $4.00. In the second quarter, IMV showed an EPS of $0.11, compared to $0.08 from the year-ago quarter. The stock has a 52-week-high of $4.95 and a 52-week-low of $1.31. At the end of the last trading period, IMV closed at $1.69.
Berenberg initiated coverage on $Viant Technology Inc.(DSP.US)$ with a Buy rating. The price target for Viant Technology is set to $20.00. Interestingly, in the second quarter, Viant Technology's EPS was $0.06. At the moment, the stock has a 52-week-high of $69.16 and a 52-week-low of $11.61. Viant Technology closed at $11.64 at the end of the last trading period.
Berenberg initiated coverage on $PUBMATIC, INC.(PUBM.US)$ with a Buy rating. The price target for PubMatic is set to $37.00. PubMatic earned $0.18 in the second quarter. At the moment, the stock has a 52-week-high of $76.96 and a 52-week-low of $22.42. PubMatic closed at $27.20 at the end of the last trading period.
With a Buy rating, Berenberg initiated coverage on $Magnite Inc(MGNI.US)$. The price target seems to have been set at $37.00 for Magnite. In the second quarter, Magnite showed an EPS of $0.11, compared to $0.10 from the year-ago quarter. The stock has a 52-week-high of $64.39 and a 52-week-low of $5.88. At the end of the last trading period, Magnite closed at $28.39.
With a Buy rating, Jefferies initiated coverage on $SoFi Technologies(SOFI.US)$. The price target seems to have been set at $25.00 for SoFi Technologies. For the second quarter, SoFi Technologies had an EPS of $0.48, compared to year-ago quarter EPS of $0.03. The current stock performance of SoFi Technologies shows a 52-week-high of $24.95 and a 52-week-low of $13.56. Moreover, at the end of the last trading period, the closing price was at $15.17.
Baird initiated coverage on $Gentherm(THRM.US)$ with an Outperform rating. The price target for Gentherm is set to $94.00. Gentherm earned $0.85 in the second quarter, compared to $0.30 in the year-ago quarter. At the moment, the stock has a 52-week-high of $88.99 and a 52-week-low of $38.99. Gentherm closed at $77.93 at the end of the last trading period.
With a Buy rating, MKM Partners initiated coverage on $California Resources Corp(CRC.US)$. The price target seems to have been set at $54.00 for California Resources. In the second quarter, California Resources earned $0.94. The current stock performance of California Resources shows a 52-week-high of $44.58 and a 52-week-low of $14.63. Moreover, at the end of the last trading period, the closing price was at $41.60.
With a Buy rating, Stifel initiated coverage on $Armada Hoffler Properties Inc(AHH.US)$. The price target seems to have been set at $15.00 for Armada Hoffler Properties. Armada Hoffler Properties earned $0.29 in the second quarter, compared to $0.29 in the year-ago quarter. At the moment, the stock has a 52-week-high of $14.38 and a 52-week-low of $8.20. Armada Hoffler Properties closed at $13.20 at the end of the last trading period.
With an Outperform rating, Oppenheimer initiated coverage on $Golub Capital BDC Inc(GBDC.US)$. The price target seems to have been set at $16.00 for Golub Capital BDC. In the third quarter, Golub Capital BDC showed an EPS of $0.29, compared to $0.28 from the year-ago quarter. At the moment, the stock has a 52-week-high of $16.22 and a 52-week-low of $12.31. Golub Capital BDC closed at $15.36 at the end of the last trading period.
憑藉買入評級，Alliance Global Partners在$IceCure Medical Ltd(ICCM.US)$。IceCure Medical的目標價格似乎被設定在14.50美元。IceCure Medical上交易日尾盤收報9.00美元。
摩根大通在$ZIM集成航運(ZIM.US)$評級偏低。ZIM集成航運的目標價設為46.02美元。第二季度，ZIM集成航運盈利7.38美元。該股目前的52周高點為62.20美元，52周低點為11.34美元。上交易期尾盤，ZIM集成船運收報55.89美元。
Evercore ISI Group在$SunPower(SPWR.US)$評級優於大盤。SunPower的目標價定為27.00美元。第二季度，SunPower的每股收益為0.06美元，而去年同期為0.22美元。SunPower目前的股票表現顯示，52周高點為57.52美元，52周低點為9.54美元。而且，在上個交易期結束時，收盤價為21.09美元。
憑藉買入評級，瑞銀在$Li-Cycle Holdings Corp(LICY.US)$。Li-Cycle Holdings的目標價似乎被設定在15.00美元。第三季度，Li-Cycle Holdings的每股收益為2.88美元，而去年同期為0.86美元。Li-Cycle Holdings上一交易期尾盤報9.85美元。
BTIG在$Humacyte Inc(HUMA.US)$評級為買入。Humacyte的目標價定為19.00美元。上交易期尾盤，Humacyte收報13.85美元。
由於增持評級，富國銀行(Wells Fargo)在$Vimeo Inc.(VMEO.US)$。Vimeo的目標價似乎被設定在47.00美元。Vimeo第二季度盈利0.02美元，而去年同期為0.05美元。目前，該股的52周高點為52.06美元，52周低點為29.17美元。Vimeo上交易日尾盤報32.39美元。
為$Poshmark，Inc.(POSH.US)$，Needham通過將當前評級設置為保持來啟動覆蓋範圍。有趣的是，在第二季度，Poshmark的每股收益為0.04美元。Poshmark目前的股票表現顯示，52周高點為104.98美元，52周低點為23.58美元。而且，在上個交易期結束時，收盤價為23.59美元。
DZ銀行於$現在服務公司(北美)$評級為買入。ServiceNow的目標價定為725.00美元。ServiceNow第二季度盈利1.42美元，而去年同期為1.23美元。ServiceNow目前的股票表現顯示，52周高點為681.10美元，52周低點為446.20美元。而且，在上個交易期結束時，收盤價為654.20美元。
加碼收視率，摩根士丹利啟動報道$Jackson Financial(JXN.US)$。傑克遜金融公司的目標價似乎被設定在37.00美元。傑克遜金融公司第二季度盈利6.74美元。而且，在上個交易期結束時，收盤價為26.53美元。
康託·菲茨傑拉德(Cantor Fitzgerald)在$IMV Inc.(IMV.US)$擁有超重評級。IMV的目標價設為4.00美元。第二季度，IMV顯示每股收益為0.11美元，而去年同期為0.08美元。該股目前的52周高點為4.95美元，52周低點為1.31美元。上交易期尾盤，IMV收報1.69美元。
貝倫伯格發起了關於$Viant Technology Inc.(DSP.US)$評級為買入。Viant Technology的目標價定為20.00美元。有趣的是，在第二季度，Viant Technology的每股收益為0.06美元。目前，該股的52周高點為69.16美元，52周低點為11.61美元。Viant Technology上一交易期尾盤報11.64美元。
貝倫伯格發起了關於$PubMatic，Inc.(PUBM.US)$評級為買入。PubMatic的目標價定為37.00美元。PubMatic第二季度盈利0.18美元。目前，該股的52周高點為76.96美元，52周低點為22.42美元。PubMatic上一交易期尾盤報27.20美元。
在獲得買入評級的情況下，貝倫伯格在$Magnite Inc(MGNI.US)$。Magnite的目標價似乎被設定在37.00美元。第二季度，Magnite的每股收益為0.11美元，而去年同期為0.10美元。該股目前的52周高點為64.39美元，52周低點為5.88美元。上交易期尾盤，Magnite收報28.39美元。
在獲得買入評級的情況下，Jefferies在$SoFi Technologies(SOFI.US)$。SoFi Technologies的目標價似乎被設定在25.00美元。第二季度，SoFi Technologies的每股收益為0.48美元，而去年同期為0.03美元。SoFi Technologies目前的股票表現顯示，52周高點為24.95美元，52周低點為13.56美元。而且，在上個交易期結束時，收盤價為15.17美元。
Baird發起了關於$Gentherm(THRM.US)$評級優於大盤。Gentherm的目標價定為94.00美元。Gentherm第二季度盈利0.85美元，而去年同期為0.30美元。目前，該股的52周高點為88.99美元，52周低點為38.99美元。Gentherm上交易日尾盤報77.93美元。
通過買入評級，MKM合作伙伴在$加州資源公司(CRC.US)$。加州資源公司的目標價似乎被設定在54.00美元。第二季度，加州資源公司的利潤為0.94美元。目前California Resources的股票表現顯示，52周高點為44.58美元，52周低點為14.63美元。而且，在上個交易期結束時，收盤價為41.60美元。
在獲得買入評級的情況下，Stifel在$Armada Hoffler Properties Inc(AHH.US)$。Armada Hoffler Properties的目標價似乎被設定在15.00美元。Armada Hoffler Properties第二季度盈利0.29美元，而去年同期為0.29美元。目前，該股的52周高點為14.38美元，52周低點為8.20美元。Armada Hoffler Properties上一交易期尾盤報13.20美元。
憑藉強於大盤的評級，奧本海默在$Golub Capital BDC Inc.(GBDC.US)$。Golub Capital BDC的目標價似乎被設定在16.00美元。第三季度，Golub Capital BDC的每股收益為0.29美元，而去年同期為0.28美元。目前，該股的52周高點為16.22美元，52周低點為12.31美元。Golub Capital BDC上一交易期尾盤報15.36美元。